![Léa Floquet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Léa Floquet
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
11
| Public Company | Biotechnology | 11 |
Universite Toulouse 1 Capitole
3
| College/University | Other Consumer Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Léa Floquet via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
TopoTarget UK Ltd.
![]() TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member | |
Kepler Cheuvreux SA
![]() Kepler Cheuvreux SA Investment Banks/BrokersFinance Kepler Cheuvreux SA is an independent broker/dealer headquartered in Paris, France. The firm was founded by Laurent Quirin in 1997. Kepler Cheuvreux provides execution services to institutional investors. It supports equities, fixed income, derivatives, ETFS, and convertible bonds across Europe, America and Asia. | Investment Banks/Brokers | Analyst-Equity | |
CIC Market Solutions SA
![]() CIC Market Solutions SA Investment Banks/BrokersFinance CIC Market Solutions SA is the broker-dealer subsidiary of Crédit Industriel et Commercial SA, ultimately owned by Groupe Crédit Mutuel in France. Headquartered in Paris, the firm was founded in 1991 and handles commercial market activities for corporate and professional investor clients of Crédit Mutuel Alliance Fédérale group. CIC Market Solutions also provides primary equity and bond market services and execution and sale on the capital markets. | Investment Banks/Brokers | Analyst-Equity | |
Emergence Therapeutics AG
![]() Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Chairman | |
Talix Therapeutics NV | Chairman | ||
BliNK Biomedical SAS
![]() BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Chief Executive Officer | |
Pharma-Lizenz-Club Deutschland | Chairman | ||
BioNet Pharma GmbH
![]() BioNet Pharma GmbH Miscellaneous Commercial ServicesCommercial Services BioNet Pharma GmbH engages in development of medical devices, pharmaceutical drugs and regenerative medical products. Its pipeline covers pre-clinical and clinical development programs in osteoarthritis, inflammatory joint disease, cartilage injury, and severe gingival inflammation. The company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Staatz Business Development & Strategy | Founder | ||
SANOFI | Pharmaceuticals: Major | General Counsel | |
INNATE PHARMA | Pharmaceuticals: Major | Chairman | |
HERMAL Kurt Herrmann GmbH & Co. oHG
![]() HERMAL Kurt Herrmann GmbH & Co. oHG Pharmaceuticals: MajorHealth Technology HERMAL Kurt Herrmann GmbH & Co. oHG provides skin care products. The company develops products for the treatment of skin related diseases. It is a dermatological company with marketing and sales departments throughout Europe and a production unit based in Germany. HERMAL Kurt Herrmann was founded in 1946 and is headquartered in Reinbek, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
Philipps University of Marburg | College/University | Undergraduate Degree | |
U3 Pharma AG
![]() U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Quadrille Capital SAS
![]() Quadrille Capital SAS Investment ManagersFinance Quadrille Capital SAS (Quadrille Capital) is an independent private equity firm founded in 2007. The firm is headquartered in Paris, France with an additional office in United States. | Investment Managers | Private Equity Investor | |
Universite Paris Cite | College/University | Graduate Degree | |
EM Lyon Business School | College/University | Undergraduate Degree | |
Georgetown University | College/University | Graduate Degree | |
L'école d'économie de Toulouse | College/University | Graduate Degree | |
Toulouse Business School - TBS EESC | College/University | Masters Business Admin | |
Founders Future SAS
![]() Founders Future SAS Investment ManagersFinance Founders Future SAS is an independent Venture Capital firm with headquarters in France, Paris. Founders Future was founded in 2017 by Marc Ménasé. | Investment Managers | General Counsel | |
Université Libre de Bruxelles | College/University | Corporate Officer/Principal | |
Health Economics & Outcomes Research Ltd.
![]() Health Economics & Outcomes Research Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Health Economics & Outcomes Research Ltd. is a British management consulting company that provides consulting services. The company is based in Cardiff, UK and is part of HEOR Holdings Ltd. | Miscellaneous Commercial Services | Director/Board Member | |
Lundbeck SAS
![]() Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Université de Limoges | College/University | Masters Business Admin | |
Swiss Re Capital Markets Corp.
![]() Swiss Re Capital Markets Corp. Investment Banks/BrokersFinance Founded in 1995, Swiss Re Capital Markets Corp. is a registered broker/dealer located in New York City. The firm is a subsidiary of Swiss Reinsurance Co. Swiss Re Capital Markets Corp. is committed to the development of a market for liquid, transparent and tradable insurance-linked risk products, leveraging their re/insurance and capital markets experience. | Investment Banks/Brokers | Economist | |
Hoechst GmbH
![]() Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Pharmaceuticals: Major | Director/Board Member | |
University of Palermo | College/University | Doctorate Degree | |
Georgetown University Law Center | College/University | Corporate Officer/Principal | |
EUROAPI | Biotechnology | Director/Board Member | |
Global Antibiotic Research & Development Partnership
![]() Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
Sanofi-Aventis Deutschland GmbH
![]() Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Director/Board Member | |
CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member | |
VEON LTD. | Wireless Telecommunications | Director/Board Member | |
INSERM Transfert Initiative SAS
![]() INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman | |
BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member | |
Chr. Hansen A/S
![]() Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member | |
Copenhagen Business School | College/University | Undergraduate Degree | |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Bavarian Nordic GmbH
![]() Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
Lundbeck Cognitive Therapeutics A/S | Director/Board Member |
Statistieken
Internationaal
Frankrijk | 17 |
Duitsland | 12 |
Denemarken | 6 |
Verenigd Koninkrijk | 6 |
Verenigde Staten | 5 |
Sectoraal
Health Technology | 19 |
Consumer Services | 15 |
Finance | 7 |
Commercial Services | 5 |
Retail Trade | 2 |
Operationeel
Director/Board Member | 39 |
Corporate Officer/Principal | 19 |
Independent Dir/Board Member | 12 |
Chairman | 11 |
Chief Executive Officer | 8 |
Sterkste connecties
- Beurs
- Insiders
- Léa Floquet
- Bedrijfsconnecties